A comparison of adverse events and quality of life before and after switching from kaletra soft-gel capsules (SGC) to kaletra tablets in an African American cohort.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Nov 2006 New trial record.